Multiparametric MRI detects multi-organ impairment in patients with chronic myeloid neoplasms with normal serum biomarkers

Sophie Reed, Charlie Diamond, Samiya Mahmood, Soubera Rymell, Michael Smith, Michele Pansini, Bethan Psaila, Adam J. Mead, Helena Thomaides-Brears, Onima Chowdhury
doi: https://doi.org/10.1101/2023.11.23.23298558

Article Information

doi 
https://doi.org/10.1101/2023.11.23.23298558
History 
  • November 23, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Sophie Reed1,2,
  2. Charlie Diamond3,
  3. Samiya Mahmood1,
  4. Soubera Rymell3,
  5. Michael Smith1,
  6. Michele Pansini1,3,
  7. Bethan Psaila1,2,
  8. Adam J. Mead1,2,
  9. Helena Thomaides-Brears3 and
  10. Onima Chowdhury1,2
  1. 1Oxford University Hospitals’ NHS Foundation Trust, Oxford, UK
  2. 2Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, NIHR, Biomedical Research Centre, University of Oxford, Oxford, UK
  3. 3Perspectum Ltd, Gemini One, 5520 John Smith Drive, Oxford, UK
  1. * Corresponding author; email: onima.chowdhury{at}ndcls.ox.ac.uk
Back to top
Posted November 23, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Multiparametric MRI detects multi-organ impairment in patients with chronic myeloid neoplasms with normal serum biomarkers
Sophie Reed, Charlie Diamond, Samiya Mahmood, Soubera Rymell, Michael Smith, Michele Pansini, Bethan Psaila, Adam J. Mead, Helena Thomaides-Brears, Onima Chowdhury
medRxiv 2023.11.23.23298558; doi: https://doi.org/10.1101/2023.11.23.23298558
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area